# Add on Lacosamide Versus High Dose Monotherapy

> **NCT01345058** · PHASE3 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 56 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** lacosamide
- **DRUG:** levetiracetam

## Key facts

- **NCT ID:** NCT01345058
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-01
- **Primary completion:** 2014-02-15
- **Final completion:** 2014-10-21
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01345058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01345058, "Add on Lacosamide Versus High Dose Monotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01345058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*